Baird Financial Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-23,047	Closed	-$86.2K	–	1721
2023 Q3	$86.2K	Sell	23,047 -2,388	-9%	-$8.93K	﹤0.01%	1675
2023 Q2	$109K	Buy	+25,435	New	+$109K	﹤0.01%	1652